Stock Analysis

Aquarius Surgical Technologies First Quarter 2025 Earnings: CA$0.008 loss per share (vs CA$0.007 loss in 1Q 2024)

CNSX:ASTI
Source: Shutterstock

Aquarius Surgical Technologies (CSE:ASTI) First Quarter 2025 Results

Key Financial Results

  • Revenue: CA$24.5k (down 54% from 1Q 2024).
  • Net loss: CA$221.6k (loss widened by 19% from 1Q 2024).
  • CA$0.008 loss per share (further deteriorated from CA$0.007 loss in 1Q 2024).
earnings-and-revenue-history
CNSX:ASTI Earnings and Revenue History August 31st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aquarius Surgical Technologies' share price is broadly unchanged from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with Aquarius Surgical Technologies, and understanding these should be part of your investment process.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.